Toward a systemic research agenda for addressing the joint epidemics of HIV/AIDS and noncommunicable diseases

AIDS ◽  
2012 ◽  
Vol 26 ◽  
pp. S7-S10 ◽  
Author(s):  
Robert Geneau ◽  
Greg Hallen
Author(s):  
Massimo Leone ◽  
Fausto Ciccacci ◽  
Stefano Orlando ◽  
Sandro Petrolati ◽  
Giovanni Guidotti ◽  
...  

Eighty percent of people with stroke live in low- to middle-income nations, particularly in sub-Saharan Africa (SSA) where stroke has increased by more than 100% in the last decades. More than one-third of all epilepsy−related deaths occur in SSA. HIV infection is a risk factor for neurological disorders, including stroke and epilepsy. The vast majority of the 38 million people living with HIV/AIDS are in SSA, and the burden of neurological disorders in SSA parallels that of HIV/AIDS. Local healthcare systems are weak. Many standalone HIV health centres have become a platform with combined treatment for both HIV and noncommunicable diseases (NCDs), as advised by the United Nations. The COVID-19 pandemic is overwhelming the fragile health systems in SSA, and it is feared it will provoke an upsurge of excess deaths due to the disruption of care for chronic diseases such as HIV, TB, hypertension, diabetes, and cerebrovascular disorders. Disease Relief through Excellent and Advanced Means (DREAM) is a health programme active since 2002 to prevent and treat HIV/AIDS and related disorders in 10 SSA countries. DREAM is scaling up management of NCDs, including neurologic disorders such as stroke and epilepsy. We described challenges and solutions to address disruption and excess deaths from these diseases during the ongoing COVID-19 pandemic.


1996 ◽  
Vol 49 (3) ◽  
pp. 5-14 ◽  
Author(s):  
Alun C. Jackson ◽  
Shane Thomas ◽  
Lydia Benntt
Keyword(s):  

Oral Diseases ◽  
2020 ◽  
Vol 26 (S1) ◽  
pp. 169-171
Author(s):  
Anwar R. Tappuni ◽  
Stephen J. Challacombe ◽  
Christopher H. Fox

Author(s):  
Zunyou Wu ◽  
Jennifer M McGoogan ◽  
Roger Detels

Abstract Nearly 17 years ago China launched its National HIV/AIDS Response Program, yet the epidemic still is not slowing. New cases and new deaths increase every year—in 2005, 40,711 people living with HIV (PLWH) were diagnosed and 5,729 died whereas in 2019, 148,598 PLWH were diagnosed and 31,522 died . Moreover, the estimated PLWH population in China has risen to >1.25 million. However, epidemic data are worryingly complex and difficult to interpret, presenting challenges to the redirection and refocusing of efforts toward achievement of control. Here we present three “windows” into China’s epidemic data. From these viewpoints, it appears we still do not know how much infection exists, how much transmission is occurring, and in what contexts transmission happens. The enigma that is China’s HIV epidemic must be better understood. A new research agenda must be developed and executed if we are to change the future of HIV in China.


AIDS Care ◽  
2008 ◽  
Vol 20 (4) ◽  
pp. 407-412 ◽  
Author(s):  
Jean-Paul Moatti ◽  
Bruno Spire

Sign in / Sign up

Export Citation Format

Share Document